Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Vita Life Sciences Limited ( (AU:VLS) ).
Vita Life Sciences Limited has provided an updated notification to the ASX regarding its on-market share buy-back program for its ordinary fully paid shares. The latest filing, dated 12 March 2026, confirms that the company is continuing its previously announced buy-back, with a total of 689,268 shares repurchased before the previous day and an additional 1,350 shares bought back on the previous day.
The update forms part of a series of daily buy-back notifications that began in May 2025 and signals an ongoing capital management strategy by Vita Life Sciences. By reducing the number of shares on issue through on-market repurchases, the company may be aiming to enhance shareholder value, support its share price, and demonstrate confidence in its financial position and future prospects.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an ASX-listed company (code VLS) operating in the life sciences sector. It has ordinary fully paid shares listed on the Australian Securities Exchange, indicating an investor base focused on the healthcare and life sciences market.
Average Trading Volume: 15,625
Technical Sentiment Signal: Buy
Current Market Cap: A$139M
See more data about VLS stock on TipRanks’ Stock Analysis page.